HDC Subsidiary Wins 297.6 Billion KRW Contract for Seoul Asan Hospital Carbon Ion Therapy Center Expansion, Boosting Revenue by 7.2%
HDC's subsidiary Ipark Hyundai Development has signed a construction contract with Seoul Asan Hospital for the expansion of the carbon ion therapy center. The contract amount is 297.6 billion KRW excluding VAT, representing 7.2% of the subsidiary's 2025 consolidated sales.
The project is scheduled for 62 months and involves building a 39,502 square meter carbon ion therapy center. This new order is expected to positively contribute to HDC's consolidated revenue growth.
The disclosure is a major management decision filing and does not directly involve capital changes or shareholder return policies.
[AI Summary]This contract win demonstrates stable order activity in HDC's core construction business, strengthening its revenue base through a contract with a high-quality counterparty Seoul Asan Hospital. While positive for short-term stock sentiment, the lack of capital changes warrants a neutral assessment.
KOSPI Filing Information
Conclusion of Single Sales/Supply Contract (Major Management Matters of Subsidiary)